Skip to main content
OCGN logo

Ocugen, Inc.

OCGNNASDAQHealthcareBiotechnology

$0.78Today:- (-)1Y −49.14%

As of Oct 16, 2026 close

Market cap
$275.58M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$0.79$2.73
Volume (live)
-
Avg. volume (3M)
8.59M

Ocugen (OCGN) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Ocugen reported total assets of $43.52M and total liabilities of $55.68M. Shareholders' equity was negative at −$12.17M, meaning liabilities exceed assets. Total debt stood at $28.79M against $18.57M in cash and short-term investments, a net debt position of $10.22M.

Ocugen Balance Sheet Analysis

Values in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Ocugen, Inc. (OCGN) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingDec 2025Dec 2024Mar 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Current Assets
Cash and Cash Equivalents18.5758.5139.4639.4677.5694.9624.047.4415.547.08
Short-Term Investments0.000.000.00-13.370.000.000.000.000.90
Cash & Short-Term Investments18.5758.5139.4639.4690.9394.9624.047.4415.547.98
Accounts Receivable0.000.000.00-0.000.000.000.000.000.00
Inventory0.000.000.00-0.000.000.000.000.000.00
Other Current Assets5.773.173.513.517.567.691.848.320.860.19
Total Current Assets24.3461.6842.9742.9798.49102.6525.8815.7716.408.18
Non-Current Assets
Property, Plant & Equipment (Net)14.3916.5517.2917.296.051.161.070.220.142.72
Long-Term Investments0.000.000.00-0.000.000.000.150.150.14
Other Non-Current Assets4.784.214.294.294.091.950.430.670.740.00
Total Non-Current Assets19.1820.7621.5821.5810.143.121.501.041.032.86
Total Assets43.5282.4464.5564.55108.63105.7627.3816.8117.4311.04
Current Liabilities
Accounts Payable6.204.243.173.178.062.310.401.901.590.78
Short-Term Debt1.251.330.57-0.500.360.230.170.000.18
Current Portion of Long-Term Debt1.251.33----0.23---
Accrued Liabilities2.1415.50-0.8819.972.612.94---
Deferred Revenue5.918.3710.5310.5311.220.000.002.2710.002.02
Other Current Liabilities3.392.822.820.158.750.292.940.211.282.85
Total Current Liabilities23.0421.5917.0917.0928.537.003.614.542.873.81
Non-Current Liabilities
Long-Term Debt27.5427.356.372.805.881.711.821.241.020.00
Deferred Tax Liabilities0.000.000.92-0.000.000.000.00-1.020.00
Other Non-Current Liabilities1.600.560.530.530.240.000.000.014.0018.50
Total Non-Current Liabilities32.6431.226.896.896.122.942.211.2515.0118.50
Total Liabilities55.6852.8123.9823.9834.659.945.835.7917.8922.30
Stockholders' Equity
Common Stock3.132.922.572.572.222.001.840.530.510.16
Retained Earnings-408.07-340.22-286.17-286.17-223.09-131.67-73.30-51.48-216.83-208.19
Accumulated Other Comprehensive Income0.060.050.020.020.030.000.000.00-10.29-10.92
Treasury Stock0.050.05-0.050.050.05----
Additional Paid-in Capital392.76366.89324.14324.19294.83225.5493.0161.97215.86196.76
Shares Outstanding312.38291.37-256.57221.60199.38----
Total Stockholders' Equity-12.1729.6340.5640.5673.9895.8221.5511.02-0.46-11.27
Total Liabilities & Equity43.5282.4464.5564.55108.63105.7627.3816.8117.4311.04

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Ocugen Balance Sheet

How much debt does Ocugen have?

Ocugen had total debt of $28.79M as of Dec 31, 2025, against $18.57M in cash and short-term investments. Total debt was $28.67M a year earlier.

What are Ocugen's total assets?

Ocugen reported total assets of $43.52M as of Dec 31, 2025, down 47.2% from $82.44M a year earlier. Total liabilities were $55.68M.

What is Ocugen's shareholders' equity?

Ocugen's shareholders' equity was negative at −$12.17M as of Dec 31, 2025, so its liabilities exceeded its assets.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition